Skip to content

Effect of thyroid hormone (Levothyroxine) treatment on cholesterol levels in adults aged 18 60 Years with metabolic syndrome and mild thyroid dysfunction at a tertiary care hospital in Haryana

Effect of levothyroxine supplementation on lipid profile in patients with metabolic syndrome having subclinical hypothyroidism of age group 18-60 years in tertiary care centre in Haryana : Quasi experimental study design - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/111119
Enrollment
100
Registered
2026-05-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E70-E88- Metabolic disorders Health Condition 2: E02- Subclinical iodine-deficiency hypothyroidism

Interventions

Intervention1: Levothyroxin: 1.5 mcg/kg/day orally,one time a day, for 12 weeks Control Intervention1: NIL: NIL

Sponsors

Dr Barkha Choudhary
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18 to 60 years 2. Diagnosed with subclinical hypothyroidism (TSH 5 to 10 mIU perL, normal fT4) 3. Diagnosis of metabolic syndrome based on ATP III criteria (3 of the following) a. Waist circumference more than 102 cm (men) or more than 88 cm (women) b. Fasting triglycerides more than or equal to 150 mg perdL c. HDL C less than 40 mg perdL (men) or less than 50 mg perdL (women) d. Blood pressure more than or equal to 130 by 85 mmHg or on antihypertensives e. Fasting glucose more than or equal to 100 mg perdL

Exclusion criteria

Exclusion criteria: 1. Overt hypothyroidism or hyperthyroidism 2. Previous thyroid surgery or radioactive iodine therapy 3. Use of lipid lowering agents in the past 3 months 4. Pregnancy or lactation 5. Severe systemic illness or malignancy

Design outcomes

Primary

MeasureTime frame
1. Change in pre and post LDL C level from baseline after 3 months 2. Changes in pre and post total cholesterol, HDL C, triglycerides from baseline after 3 monthsTimepoint: 3 months from the date of recruitment

Secondary

MeasureTime frame
Change in pre and post TSH and fT4 from baseline after 3 monthsTimepoint: 3 months from the date of recruitment

Countries

India

Contacts

Public ContactDr Barkha Choudhary

Maharaja Agrasen Medical College, Agroha

deepakgahlan25@gmail.com8059844515

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026